首页 > 最新文献

Current Women s Health Reviews最新文献

英文 中文
Comparison of The Effect of Oral Sodium Bicarbonate And Tolterodine In Women with Symptoms of Overactive Bladder with Acidic Urine- A Single-Blind Randomized Clinical Trial 口服碳酸氢钠和托特罗定治疗膀胱过度活动伴酸性尿的疗效比较——一项单盲随机临床试验
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-11-25 DOI: 10.2174/1573404819666221125095418
Samira Dehghani, T. J. Bozorgan, A. Mahmoodi, Reza Hosseiniara
Urine alkalinization with oral sodium bicarbonate seems to improve urinary symptoms in female patients with overactive bladder with acidic urinary pH.Therefore, the aim of this study was to compare the effect of oral sodium bicarbonate and tolterodine in women with symptoms of overactive bladder with acidic urinary pH.In this single-blind randomized clinical trial, 72 female patients with symptoms of overactive bladder syndrome with acidic urinary pH in the age group of 28-60 years were referred to the gynecology clinic of Mahdieh Hospital affiliated with Shahid Beheshti University of Medical Sciences, Tehran, Iran in 2021-2022 were studied. These patients were randomly divided into two groups oral sodium bicarbonate (36 patients) and tolterodine group (36 patients) and received the treatment for one month. Group matching was performed between patients. At the end of the study, the Overactive Bladder–Validated 8-question Awareness tool (OAB-V8), frequency, nocturia, urgency, and urinary incontinence (UI) was measured and compared between patients in the two groups.Patients were matched for age, underlying disease, BMI, acidic urinary pH, and menopause status at the baseline. After 30 days of medication therapy, a significant decrease in OAB-V8 score, frequency, nocturia, urgency, and urinary incontinence (UI) was observed in both groups receiving oral sodium bicarbonate and tolterodine in female patients with symptoms of overactive bladder syndrome with acidic urine. The degree of improvement in outcomes after treatment was similar between both groups.Oral sodium bicarbonate administration in patients with overactive bladder with acidic urinary pH has a significant positive effect on OAB-V8 symptoms, frequency, nocturia, urgency, and urinary incontinence (UI) and these results are similar to tolterodine treatment. Given that the acidic urinary pH may play a role in the etiology of an overactive bladder, it seems that sodium bicarbonate improves the symptoms of an overactive bladder by alkalizing the urine.
口服碳酸氢钠碱化尿液似乎可以改善女性膀胱过度活动并酸性尿ph患者的泌尿症状。因此,本研究的目的是比较口服碳酸氢钠和托特罗定对女性膀胱过度活动并酸性尿ph症状的影响。研究了伊朗德黑兰Shahid Beheshti医科大学附属Mahdieh医院2021-2022年妇科门诊就诊的72例年龄28-60岁的女性膀胱过动综合征症状伴酸性尿pH。随机分为口服碳酸氢钠组(36例)和托特罗定组(36例),疗程1个月。患者间进行分组匹配。在研究结束时,测量并比较两组患者的膀胱过度活动验证8问题意识工具(OAB-V8)、尿频、夜尿、尿急和尿失禁(UI)。患者的年龄、基础疾病、BMI、酸性尿液pH值和基线时的绝经状态相匹配。经药物治疗30天后,两组口服碳酸氢钠和托特罗定的有膀胱过度活动综合征症状的女性患者,OAB-V8评分、尿频、夜尿、尿急、尿失禁(UI)均显著降低。两组治疗后预后改善程度相似。膀胱过度活动伴酸性尿pH患者口服碳酸氢钠对OAB-V8症状、尿频、夜尿、尿急和尿失禁(UI)均有显著的积极作用,这些结果与托特罗定治疗相似。鉴于酸性尿液pH值可能在膀胱过度活动的病因中起作用,碳酸氢钠似乎通过碱化尿液来改善膀胱过度活动的症状。
{"title":"Comparison of The Effect of Oral Sodium Bicarbonate And Tolterodine In Women with Symptoms of Overactive Bladder with Acidic Urine- A Single-Blind Randomized Clinical Trial","authors":"Samira Dehghani, T. J. Bozorgan, A. Mahmoodi, Reza Hosseiniara","doi":"10.2174/1573404819666221125095418","DOIUrl":"https://doi.org/10.2174/1573404819666221125095418","url":null,"abstract":"\u0000\u0000Urine alkalinization with oral sodium bicarbonate seems to improve urinary symptoms in female patients with overactive bladder with acidic urinary pH.\u0000\u0000\u0000\u0000Therefore, the aim of this study was to compare the effect of oral sodium bicarbonate and tolterodine in women with symptoms of overactive bladder with acidic urinary pH.\u0000\u0000\u0000\u0000In this single-blind randomized clinical trial, 72 female patients with symptoms of overactive bladder syndrome with acidic urinary pH in the age group of 28-60 years were referred to the gynecology clinic of Mahdieh Hospital affiliated with Shahid Beheshti University of Medical Sciences, Tehran, Iran in 2021-2022 were studied. These patients were randomly divided into two groups oral sodium bicarbonate (36 patients) and tolterodine group (36 patients) and received the treatment for one month. Group matching was performed between patients. At the end of the study, the Overactive Bladder–Validated 8-question Awareness tool (OAB-V8), frequency, nocturia, urgency, and urinary incontinence (UI) was measured and compared between patients in the two groups.\u0000\u0000\u0000\u0000Patients were matched for age, underlying disease, BMI, acidic urinary pH, and menopause status at the baseline. After 30 days of medication therapy, a significant decrease in OAB-V8 score, frequency, nocturia, urgency, and urinary incontinence (UI) was observed in both groups receiving oral sodium bicarbonate and tolterodine in female patients with symptoms of overactive bladder syndrome with acidic urine. The degree of improvement in outcomes after treatment was similar between both groups.\u0000\u0000\u0000\u0000Oral sodium bicarbonate administration in patients with overactive bladder with acidic urinary pH has a significant positive effect on OAB-V8 symptoms, frequency, nocturia, urgency, and urinary incontinence (UI) and these results are similar to tolterodine treatment. Given that the acidic urinary pH may play a role in the etiology of an overactive bladder, it seems that sodium bicarbonate improves the symptoms of an overactive bladder by alkalizing the urine.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"81 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80974910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consequences of Concurrent Myomectomy and Caesarean Section versus Caesarean Section Alone in the Last Two Decades: Systematic Review and Meta-analysis 在过去的二十年中,子宫肌瘤切除术和剖宫产术与单独剖宫产术的结果:系统回顾和荟萃分析
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-11-15 DOI: 10.2174/1573404819666221115113516
Maryam Vaezi, Maryam Mohammadi Youshanloie, Fariba Pashazadeh
Performing myomectomy concurrently with a caesarean section has been controversial for many decades.The present study mainly aims to evaluate the consequences of concurrent myomectomy and caesarean section versus caesarean section alone.In this systematic review, we have followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Electronic resources, such as MEDLINE, Cochrane, EMBASE, Scopus, and PubMed, were searched. A total of 3057 articles were reviewed. Of these, 33 met the inclusion criteria and were included in the final analysis. The reviewed outcomes were hemoglobin (Hb) before and after the operation, blood transfusion rate, hemorrhage, operation time, duration of hospitalization, and complications, such as fever.A meta-analysis of 33 articles with 5586 participants in the caesarean myomectomy (CM) group and 2935 participants in the caesarean section (CS) group showed a statistically significant Hb decrease in the CM group [MD = 0.26, CI=95%(-0.33 to -0.19)]. The transfusion rate was higher in the CM group [OR=0.39(0.42-0.67)], and intraoperative hemorrhage was higher in the CM group [OR=0.56 (0.45 - 0.75) CI=95%]. The mean operation time [MD=1.17(1.10 -1.24) CI=95] and hospitalization time [MD=0.41 (0.34-0.48) CI=95%] were significantly higher in the CM group. There was no significant difference in the incidence of fever between the two groups [MD =1.06, CI=95%, p=0.923(0.78-1.43)].Concurrent CM is associated with a reduction in mean Hb and an increase in operation time and hospitalization time; however, it prevents additional surgery and costs; it is worthwhile to perform myomectomy at the time of caesarean section, especially by experienced surgeons with necessary preparations.
子宫肌瘤切除术与剖宫产术同时进行,几十年来一直存在争议。本研究主要目的是评价子宫肌瘤切除联合剖宫产术与单独剖宫产术的效果。在本系统评价中,我们遵循了系统评价和荟萃分析的首选报告项目(PRISMA)指南。检索了MEDLINE、Cochrane、EMBASE、Scopus和PubMed等电子资源。共审阅了3057篇文章。其中33例符合纳入标准,纳入最后分析。回顾的结果包括手术前后血红蛋白(Hb)、输血率、出血量、手术时间、住院时间和并发症(如发热)。一项对33篇文章的荟萃分析显示,剖宫产肌瘤切除术(CM)组5586名参与者和剖宫产术(CS)组2935名参与者的Hb下降在CM组有统计学意义[MD = 0.26, CI=95%(-0.33 ~ -0.19)]。CM组输血率较高[OR=0.39(0.42 ~ 0.67)],术中出血发生率较高[OR=0.56 (0.45 ~ 0.75) CI=95%]。CM组平均手术时间[MD=1.17(1.10 ~ 1.24) CI=95]和住院时间[MD=0.41 (0.34 ~ 0.48) CI=95%]显著高于CM组。两组患者发热发生率比较,差异无统计学意义[MD =1.06, CI=95%, p=0.923(0.78 ~ 1.43)]。并发CM与平均Hb降低、手术时间和住院时间增加有关;然而,它可以避免额外的手术和费用;子宫肌瘤切除术是值得在剖宫产时进行的,特别是由经验丰富的外科医生进行必要的准备。
{"title":"Consequences of Concurrent Myomectomy and Caesarean Section versus Caesarean Section Alone in the Last Two Decades: Systematic Review and Meta-analysis","authors":"Maryam Vaezi, Maryam Mohammadi Youshanloie, Fariba Pashazadeh","doi":"10.2174/1573404819666221115113516","DOIUrl":"https://doi.org/10.2174/1573404819666221115113516","url":null,"abstract":"\u0000\u0000Performing myomectomy concurrently with a caesarean section has been controversial for many decades.\u0000\u0000\u0000\u0000The present study mainly aims to evaluate the consequences of concurrent myomectomy and caesarean section versus caesarean section alone.\u0000\u0000\u0000\u0000In this systematic review, we have followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Electronic resources, such as MEDLINE, Cochrane, EMBASE, Scopus, and PubMed, were searched. A total of 3057 articles were reviewed. Of these, 33 met the inclusion criteria and were included in the final analysis. The reviewed outcomes were hemoglobin (Hb) before and after the operation, blood transfusion rate, hemorrhage, operation time, duration of hospitalization, and complications, such as fever.\u0000\u0000\u0000\u0000A meta-analysis of 33 articles with 5586 participants in the caesarean myomectomy (CM) group and 2935 participants in the caesarean section (CS) group showed a statistically significant Hb decrease in the CM group [MD = 0.26, CI=95%(-0.33 to -0.19)]. The transfusion rate was higher in the CM group [OR=0.39(0.42-0.67)], and intraoperative hemorrhage was higher in the CM group [OR=0.56 (0.45 - 0.75) CI=95%]. The mean operation time [MD=1.17(1.10 -1.24) CI=95] and hospitalization time [MD=0.41 (0.34-0.48) CI=95%] were significantly higher in the CM group. There was no significant difference in the incidence of fever between the two groups [MD =1.06, CI=95%, p=0.923(0.78-1.43)].\u0000\u0000\u0000\u0000Concurrent CM is associated with a reduction in mean Hb and an increase in operation time and hospitalization time; however, it prevents additional surgery and costs; it is worthwhile to perform myomectomy at the time of caesarean section, especially by experienced surgeons with necessary preparations.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"8 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84531825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meet the Editorial Board Member 认识编辑委员会成员
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-11-01 DOI: 10.2174/157340481804220526154648
C. Liverani
{"title":"Meet the Editorial Board Member","authors":"C. Liverani","doi":"10.2174/157340481804220526154648","DOIUrl":"https://doi.org/10.2174/157340481804220526154648","url":null,"abstract":"<jats:sec>\u0000<jats:title />\u0000<jats:p />\u0000</jats:sec>","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"153 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83561130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Maternal and Neonatal Outcomes among COVID-19 and Healthy Pregnant Women in the West of Iran: A Retrospective Cohort Study 伊朗西部COVID-19和健康孕妇的孕产妇和新生儿结局比较:一项回顾性队列研究
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-11-01 DOI: 10.2174/1573404819666221101124433
Fariba Daneshvar, N. Radnia, N. Alimohammadi, Maryam Garousian, E. Talebi-Ghane, B. Basiri, S. Bashirian, Tahereh Eskandarlo
In the COVID-19 epidemic, pregnant women, fetuses, and newborns are ahigh-risk population that is more susceptible than the general population. These groups are more susceptible to serious respiratory illnesses and pneumonia because of their weakened immune systems.This study compared maternal and neonatal outcomes in postpartum women with COVID-19 withsimilar healthy women at the hospitalIn this retrospective cohort study, the characteristics of 100 pregnantwomen with COVID-19 (confirmed by a positive PCR test during pregnancy) were compared to 150healthy pregnant women who were referred to Fatemieh Hospital in Hamadan from March, 2020 toFebruary, 2021. The maternal and neonatal outcomes were collected from the medical record of patients and analyzed using SPSS software (Ver. 26).No significant differences were observed in the average ages (± standard deviation) of thetwo groups of COVID-19 (30.25 ± 6.24 years) and healthy (29.48 ± 6.73 years) women. In this study,pregnant women were infected with COVID-19 from weeks 7 to 41 of gestation, with a median infection time of 35 weeks. The odds ratio (95% confidence interval) of pre-eclampsia and preterm birthwas significantly higher in women with COVID-19 than in healthy women with the following values2.79 (1.61, 7.34) and 22.26 (2.86, 173.33), respectively.Pregnant women suffering from COVID-19 had considerably greater rates of gestationalissues, neonatal difficulties, pre-eclampsia, and premature delivery, according to the findings of thisstudy. During epidemics, it is advised that pregnant women and their newborns receive more basiccare.
在COVID-19疫情中,孕妇、胎儿和新生儿是高危人群,比一般人群更容易感染。这些人群更容易患严重的呼吸道疾病和肺炎,因为他们的免疫系统较弱。在这项回顾性队列研究中,将100名COVID-19孕妇(妊娠期间PCR检测阳性)的特征与2020年3月至2021年2月在哈马丹Fatemieh医院转诊的150名健康孕妇的特征进行了比较。从患者病历中收集产妇和新生儿结局,并使用SPSS软件(第26版)进行分析。两组新冠肺炎患者(30.25±6.24岁)和健康女性(29.48±6.73岁)的平均年龄(±标准差)差异无统计学意义。在这项研究中,孕妇在妊娠7周至41周感染COVID-19,中位感染时间为35周。COVID-19女性子痫前期和早产的比值比(95%可信区间)显著高于健康女性,分别为2.79(1.61,7.34)和22.26(2.86,173.33)。根据这项研究的结果,患有COVID-19的孕妇出现妊娠问题、新生儿困难、先兆子痫和早产的几率要高得多。在流行病期间,建议孕妇及其新生儿获得更多的基本护理。
{"title":"Comparison of Maternal and Neonatal Outcomes among COVID-19 and Healthy Pregnant Women in the West of Iran: A Retrospective Cohort Study","authors":"Fariba Daneshvar, N. Radnia, N. Alimohammadi, Maryam Garousian, E. Talebi-Ghane, B. Basiri, S. Bashirian, Tahereh Eskandarlo","doi":"10.2174/1573404819666221101124433","DOIUrl":"https://doi.org/10.2174/1573404819666221101124433","url":null,"abstract":"\u0000\u0000In the COVID-19 epidemic, pregnant women, fetuses, and newborns are a\u0000high-risk population that is more susceptible than the general population. These groups are more susceptible to serious respiratory illnesses and pneumonia because of their weakened immune systems.\u0000This study compared maternal and neonatal outcomes in postpartum women with COVID-19 with\u0000similar healthy women at the hospital\u0000\u0000\u0000\u0000In this retrospective cohort study, the characteristics of 100 pregnant\u0000women with COVID-19 (confirmed by a positive PCR test during pregnancy) were compared to 150\u0000healthy pregnant women who were referred to Fatemieh Hospital in Hamadan from March, 2020 to\u0000February, 2021. The maternal and neonatal outcomes were collected from the medical record of patients and analyzed using SPSS software (Ver. 26).\u0000\u0000\u0000\u0000No significant differences were observed in the average ages (± standard deviation) of the\u0000two groups of COVID-19 (30.25 ± 6.24 years) and healthy (29.48 ± 6.73 years) women. In this study,\u0000pregnant women were infected with COVID-19 from weeks 7 to 41 of gestation, with a median infection time of 35 weeks. The odds ratio (95% confidence interval) of pre-eclampsia and preterm birth\u0000was significantly higher in women with COVID-19 than in healthy women with the following values\u00002.79 (1.61, 7.34) and 22.26 (2.86, 173.33), respectively.\u0000\u0000\u0000\u0000Pregnant women suffering from COVID-19 had considerably greater rates of gestational\u0000issues, neonatal difficulties, pre-eclampsia, and premature delivery, according to the findings of this\u0000study. During epidemics, it is advised that pregnant women and their newborns receive more basic\u0000care.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"57 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84797319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progesterone and Treatment for Preterm Birth: Past, Present and Future 孕激素与早产的治疗:过去,现在和未来
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-08-19 DOI: 10.2174/1573404819666220819140954
Katherine Bracamontes, R. Garfield
Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality in the United States and worldwide. Efforts to predict and delay preterm birth have been largely unsuccessful thus far. This paper seeks to illuminate the history and relevant discoveries regarding the role of progesterone in the prevention of PTB, which includes maintaining quiescence of the myometrium and counteracting cervical ripening. We will review the outcomes and methodologies of recent clinical trials, which have led to debate over the efficacy of progesterone in delaying PTB among at-risk women. The aim of this paper is to explore the historical and scientific basis for progestin treatments in the prevention of PTB, briefly discuss the results of recent clinical trials, and suggest direction for future research.
早产(PTB)仍然是美国和全世界新生儿发病率和死亡率的主要原因。迄今为止,预测和延迟早产的努力基本上是不成功的。本文旨在阐明黄体酮在预防PTB中的作用的历史和相关发现,其中包括维持子宫肌层的静止和抵消宫颈成熟。我们将回顾最近的临床试验的结果和方法,这些试验导致了对黄体酮延缓高危妇女患肺结核疗效的争论。本文旨在探讨黄体酮治疗预防肺结核的历史和科学依据,简要讨论近期临床试验的结果,并提出今后的研究方向。
{"title":"Progesterone and Treatment for Preterm Birth: Past, Present and Future","authors":"Katherine Bracamontes, R. Garfield","doi":"10.2174/1573404819666220819140954","DOIUrl":"https://doi.org/10.2174/1573404819666220819140954","url":null,"abstract":"\u0000\u0000Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality in the United States and worldwide. Efforts to predict and delay preterm birth have been largely unsuccessful thus far. This paper seeks to illuminate the history and relevant discoveries regarding the role of progesterone in the prevention of PTB, which includes maintaining quiescence of the myometrium and counteracting cervical ripening. We will review the outcomes and methodologies of recent clinical trials, which have led to debate over the efficacy of progesterone in delaying PTB among at-risk women. The aim of this paper is to explore the historical and scientific basis for progestin treatments in the prevention of PTB, briefly discuss the results of recent clinical trials, and suggest direction for future research.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"34 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78786374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing Maternal Fatigue During Childbirth: A Systematic Review 管理产妇疲劳分娩:一个系统的回顾
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-08-04 DOI: 10.2174/1573404819666220804163125
Kunnikar Chaisitsanguan, Puangpaka Kongwattananon, Dawn Hawthrone
Fatigue is a complex phenomenon. It is a common problem that occurs at all periods of childbearing. Pregnancy and labor are recognized as a normal physiological process, and fatigue, a common symptom that occurs frequently throughout the childbearing experience, has the potential to negatively affect the woman’s prenatal and birth experience. Fatigue is often overlooked by health professionals.The aim of this systematic review is to review the literature regarding the factors influencing maternal fatigue during childbirth and its management.The Joanna Briggs Institute (JBI) systematic review was used to guide this study. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was performed to report this systematic review. The database was searched from CINALH, Pubmed, PsyInfo, ThaiJO, and other sources for grey literature from 1990-2021. The methodological quality process used the critical appraisal tool for RCT study and MINORS (Methodological Index for Non-randomized Studies). Nine published articles were selected for this study.The factors influencing maternal fatigue during childbirth were found to be physiological, psychological, and situational. The physiological factors were age, parity, uterine contractility, available energy substrate, nutrition adequacy, and prenatal exercise. The psychological factors were pain and anxiety. The situational factors were childbirth education, pain medication, prenatal employment, sleep, breathing technique, and pushing intervention. The managing of fatigue during childbirth were 1) assessing maternal fatigue in early pregnancy; 2) childbirth preparation; 3) conservation of energy; 4) shortened duration of labor; and 5) reduced labor pain and anxiety.Maternal fatigue during childbirth impacts the mother, the child, and the family. It is important for nurses to understand the deleterious effects of fatigue on childbearing women and to promote interventions that reduce or prevent fatigue during pregnancy and childbirth.
疲劳是一种复杂的现象。这是一个普遍的问题,发生在生育的各个时期。怀孕和分娩被认为是一个正常的生理过程,疲劳是在整个生育过程中经常出现的一种常见症状,有可能对妇女的产前和分娩经历产生负面影响。疲劳常常被卫生专业人员所忽视。本系统综述的目的是回顾有关影响分娩时产妇疲劳及其处理的因素的文献。采用乔安娜布里格斯研究所(Joanna Briggs Institute, JBI)的系统评价来指导本研究。采用系统评价和荟萃分析首选报告项目(PRISMA)来报告该系统评价。数据库从CINALH、Pubmed、PsyInfo、ThaiJO和其他来源检索1990-2021年的灰色文献。方法学质量过程使用RCT研究的关键评价工具和未成年人(非随机研究的方法学指数)。本研究选取了9篇已发表的文章。影响分娩时产妇疲劳的因素有生理性、心理性和情境性。生理因素包括年龄、胎次、子宫收缩力、有效能量基质、营养充足性和产前运动。心理因素为疼痛和焦虑。情境因素包括分娩教育、止痛药、产前就业、睡眠、呼吸技巧和推入干预。分娩疲劳管理:1)评估妊娠早期产妇疲劳;2)分娩准备;3)能量守恒;4)缩短劳动时间;5)减少分娩疼痛和焦虑。分娩期间的产妇疲劳会影响母亲、孩子和家庭。护士必须了解疲劳对育龄妇女的有害影响,并促进干预措施,减少或预防怀孕和分娩期间的疲劳。
{"title":"Managing Maternal Fatigue During Childbirth: A Systematic Review","authors":"Kunnikar Chaisitsanguan, Puangpaka Kongwattananon, Dawn Hawthrone","doi":"10.2174/1573404819666220804163125","DOIUrl":"https://doi.org/10.2174/1573404819666220804163125","url":null,"abstract":"\u0000\u0000Fatigue is a complex phenomenon. It is a common problem that occurs at all periods of childbearing. Pregnancy and labor are recognized as a normal physiological process, and fatigue, a common symptom that occurs frequently throughout the childbearing experience, has the potential to negatively affect the woman’s prenatal and birth experience. Fatigue is often overlooked by health professionals.\u0000\u0000\u0000\u0000The aim of this systematic review is to review the literature regarding the factors influencing maternal fatigue during childbirth and its management.\u0000\u0000\u0000\u0000The Joanna Briggs Institute (JBI) systematic review was used to guide this study. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was performed to report this systematic review. The database was searched from CINALH, Pubmed, PsyInfo, ThaiJO, and other sources for grey literature from 1990-2021. The methodological quality process used the critical appraisal tool for RCT study and MINORS (Methodological Index for Non-randomized Studies). Nine published articles were selected for this study.\u0000\u0000\u0000\u0000The factors influencing maternal fatigue during childbirth were found to be physiological, psychological, and situational. The physiological factors were age, parity, uterine contractility, available energy substrate, nutrition adequacy, and prenatal exercise. The psychological factors were pain and anxiety. The situational factors were childbirth education, pain medication, prenatal employment, sleep, breathing technique, and pushing intervention. The managing of fatigue during childbirth were 1) assessing maternal fatigue in early pregnancy; 2) childbirth preparation; 3) conservation of energy; 4) shortened duration of labor; and 5) reduced labor pain and anxiety.\u0000\u0000\u0000\u0000Maternal fatigue during childbirth impacts the mother, the child, and the family. It is important for nurses to understand the deleterious effects of fatigue on childbearing women and to promote interventions that reduce or prevent fatigue during pregnancy and childbirth.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"26 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80695214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Umbilical Cord Arterial Blood Gas and Neonatal Outcomes in Women with and without Meconium-Stained Amniotic Fluid During Labor 产程中羊水有粪和无粪的妇女脐带动脉血气和新生儿结局的比较
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-08-04 DOI: 10.2174/1573404819666220804091008
M. Dehghan, Sanaz Mousavi, Aisan Akhgari, Maryam Hoseinzadeh, M. Mirghafourvand, Rosa Tafreshi, L. Nikniaz
Meconium-stained amniotic fluid (MSAF) may increase maternal and neonatal complications. The favorable mode of delivery is controversial in women with MSAF. This study aimed to compare umbilical cord arterial blood gas (ABG) and neonatal outcomes in deliveries complicated by meconium and clear amniotic fluid during the active phase of labor.This observational study was performed on 144 term pregnant women (72 with MSAF and 72 with clear amniotic fluid) during the active phase of labor with ruptured membranes admitted to Al-Zahra and Taleghani hospitals in Tabriz, Iran from June 2019 to June 2020. A checklist was used to record the ABG and neonatal outcomes.The frequency of cesarean delivery in the MSAF group (25%) was significantly higher than in the women with clear amniotic fluid (20%) (P= 0.006). There was no statistically significant difference between the groups regarding pH, base excess, PCO2, 1- and 5- minute Apgar scores, and neonatal intensive care unit (NICU) admission of the newborn due to MSAF (P> 0.05). There was no incidence of hypoxic-ischemic encephalopathy, sepsis, and seizure.Given the non-significant difference between two groups of women with and without MSAF during labor in terms of neonatal outcomes and umbilical cord ABG, it seems that MSAF alone is not an indication for cesarean delivery. Thus, vaginal delivery is recommended in pregnant women with MSAF.
羊水粪染色(MSAF)可能增加产妇和新生儿并发症。对MSAF妇女有利的分娩方式存在争议。本研究旨在比较产程活跃期伴有胎粪和清羊水的产妇脐带动脉血气(ABG)和新生儿结局。本观察性研究对2019年6月至2020年6月在伊朗大不里士的Al-Zahra和Taleghani医院住院的144名产程活跃期胎膜破裂的足月孕妇(72名患有MSAF, 72名羊水清澈)进行了研究。使用检查表记录ABG和新生儿结局。MSAF组剖宫产率(25%)显著高于羊水清澈组(20%)(P= 0.006)。两组间pH值、碱过量、二氧化碳分压、1分钟和5分钟Apgar评分以及新生儿因MSAF而入住新生儿重症监护病房(NICU)的差异无统计学意义(P < 0.05)。没有缺氧缺血性脑病、败血症和癫痫发作的发生。考虑到两组有和没有MSAF的妇女在分娩期间新生儿结局和脐带ABG方面没有显著差异,似乎MSAF本身并不是剖宫产的指征。因此,建议阴道分娩的孕妇与MSAF。
{"title":"Comparison of Umbilical Cord Arterial Blood Gas and Neonatal Outcomes in Women with and without Meconium-Stained Amniotic Fluid During Labor","authors":"M. Dehghan, Sanaz Mousavi, Aisan Akhgari, Maryam Hoseinzadeh, M. Mirghafourvand, Rosa Tafreshi, L. Nikniaz","doi":"10.2174/1573404819666220804091008","DOIUrl":"https://doi.org/10.2174/1573404819666220804091008","url":null,"abstract":"\u0000\u0000Meconium-stained amniotic fluid (MSAF) may increase maternal and neonatal complications. The favorable mode of delivery is controversial in women with MSAF. This study aimed to compare umbilical cord arterial blood gas (ABG) and neonatal outcomes in deliveries complicated by meconium and clear amniotic fluid during the active phase of labor.\u0000\u0000\u0000\u0000This observational study was performed on 144 term pregnant women (72 with MSAF and 72 with clear amniotic fluid) during the active phase of labor with ruptured membranes admitted to Al-Zahra and Taleghani hospitals in Tabriz, Iran from June 2019 to June 2020. A checklist was used to record the ABG and neonatal outcomes.\u0000\u0000\u0000\u0000The frequency of cesarean delivery in the MSAF group (25%) was significantly higher than in the women with clear amniotic fluid (20%) (P= 0.006). There was no statistically significant difference between the groups regarding pH, base excess, PCO2, 1- and 5- minute Apgar scores, and neonatal intensive care unit (NICU) admission of the newborn due to MSAF (P> 0.05). There was no incidence of hypoxic-ischemic encephalopathy, sepsis, and seizure.\u0000\u0000\u0000\u0000Given the non-significant difference between two groups of women with and without MSAF during labor in terms of neonatal outcomes and umbilical cord ABG, it seems that MSAF alone is not an indication for cesarean delivery. Thus, vaginal delivery is recommended in pregnant women with MSAF.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"9 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89563848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of postbiotics on depressive symptoms and polycystic ovary syndrome (PCOS) in human health: A short review 后生物制剂对人类健康中抑郁症状和多囊卵巢综合征(PCOS)的影响:简要综述
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-08-04 DOI: 10.2174/1573404819666220804093852
Mohadeseh Pirhadi, G. Khaniki, A. Nejad, P. Sadighara
Postbiotics are known as preparations comprising inert microorganisms and/or their ingredients that activate health profits on the host. They motivate the intestine microbiome and back the gut immune activity and prevent the duplication of pathogenic microorganisms as well. Although postbiotics are a type of probiotic waste, they can apply some beneficial effects on human health such as anti-obesity, antioxidant, immunomodulatory, and anti-carcinogenic. Accordingly, many studies suggested a conclusive effect of postbiotics on polycystic ovary syndrome (PCOS) in women and depressive symptomatology. The aim of our study was to provide an updated review of these subjects. We conducted a systematic search of literature in multiple databases such as Web of Science, Google Scholar, Science Direct, and PubMed based on some keywords. In the current review, we have focused on an effective, better understanding of postbiotics on consumers’ health and present a base for future investigation.
后生物制剂被称为含有惰性微生物和/或其成分的制剂,可激活宿主的健康效益。它们激发肠道微生物群,支持肠道免疫活动,并防止致病微生物的复制。虽然后益生菌是一种益生菌废物,但它们对人体健康具有抗肥胖、抗氧化、免疫调节、抗癌等有益作用。因此,许多研究表明,后生物制剂对女性多囊卵巢综合征(PCOS)和抑郁症状有决定性的影响。我们研究的目的是提供这些主题的最新综述。我们对Web of Science、Google Scholar、Science Direct、PubMed等多个数据库进行了基于部分关键词的文献系统检索。在当前的综述中,我们的重点是有效地,更好地了解后生物制剂对消费者健康的影响,并为未来的研究奠定基础。
{"title":"The effect of postbiotics on depressive symptoms and polycystic ovary syndrome (PCOS) in human health: A short review","authors":"Mohadeseh Pirhadi, G. Khaniki, A. Nejad, P. Sadighara","doi":"10.2174/1573404819666220804093852","DOIUrl":"https://doi.org/10.2174/1573404819666220804093852","url":null,"abstract":"\u0000\u0000Postbiotics are known as preparations comprising inert microorganisms and/or their ingredients that activate health profits on the host. They motivate the intestine microbiome and back the gut immune activity and prevent the duplication of pathogenic microorganisms as well. Although postbiotics are a type of probiotic waste, they can apply some beneficial effects on human health such as anti-obesity, antioxidant, immunomodulatory, and anti-carcinogenic. Accordingly, many studies suggested a conclusive effect of postbiotics on polycystic ovary syndrome (PCOS) in women and depressive symptomatology. The aim of our study was to provide an updated review of these subjects. We conducted a systematic search of literature in multiple databases such as Web of Science, Google Scholar, Science Direct, and PubMed based on some keywords. In the current review, we have focused on an effective, better understanding of postbiotics on consumers’ health and present a base for future investigation.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"159 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87276184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Behavioral Economics in the Delivery of Women’s Health:Next Horizons for Improvements in Practice 妇女保健服务中的行为经济学:改进实践的新视野
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-08-01 DOI: 10.2174/157340481903221130143502
John Yeh
{"title":"Behavioral Economics in the Delivery of Women’s Health:\u0000Next Horizons for Improvements in Practice","authors":"John Yeh","doi":"10.2174/157340481903221130143502","DOIUrl":"https://doi.org/10.2174/157340481903221130143502","url":null,"abstract":"<jats:sec>\u0000<jats:title />\u0000<jats:p />\u0000</jats:sec>","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"8 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79495286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the effect of jalinus syrup and ondansetron syrup on nausea and vomiting during pregnancy in pregnant women: randomized clinical trial jalinus糖浆与ondansetron糖浆对孕妇妊娠期恶心呕吐效果的比较:随机临床试验
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2022-06-29 DOI: 10.2174/1573404819666220629100218
A. Shayan, S. Nazari, S. Nazari, H. Ahmadinia, M. Rahnavardi, F. Shobeiri, R. Bekhradi, A. Khalili
This study aimed to compare the effect of jainus syrup and Ondansetron syrup on nausea and vomiting during pregnancy.The present study isa single-blindrandomized clinical trial that was conducted on 120 pregnant womenreferred to the health centers of Hamadan during 2017-2018 year.The participants were randomly divided into two groups of control and intervention with 60 subjects in each group.Two groups of 60 received jalinus syrup and Ondansetron syrup for 7 days. Data collection tools, demographic questionnaire, and information associated with pregnancy, and PUQE-24 questionnaire were used to assess the severity of nausea and vomiting, and questions related to the assessment of side effects as well asparticipants’ level of satisfaction with the treatment were provided. All the data were analyzed using the SPSS software version 16. P-value < 0.05 was considered significant.The severity of nausea and vomiting in both groups decreased after the intervention, but considering the independent t-test, there was no significant difference between the two groups in terms of severity of nausea (P <0.05). According to the Chi-square test, the severity of nausea of all participants was moderate in both groups before taking the medication, and after taking the medication, the severity of nausea reduced in most participants and they were placed in the mild group.Education based on the theory of planned behavior could significantly affect the fear of childbirth and increase the vaginal delivery rateDue to the similar effects of jalinus syrup and Ondansetron syrup in the treatment of nausea and vomiting in pregnancy and the absence of side effects arising from its use, herbal medicine can be used instead of chemical drugs.
本研究旨在比较耆那士糖浆和昂丹司琼糖浆对妊娠期恶心呕吐的影响。本研究是一项单盲临床试验,对2017-2018年期间在哈马丹卫生中心就诊的120名孕妇进行了研究。研究对象随机分为对照组和干预组,每组60人。两组60名患者分别服用jalinus糖浆和Ondansetron糖浆,疗程7天。使用数据收集工具、人口统计问卷、妊娠相关信息和PUQE-24问卷来评估恶心和呕吐的严重程度,并提供与副作用评估相关的问题以及参与者对治疗的满意度。所有数据采用SPSS软件16版进行分析。p值< 0.05为显著性。干预后两组患者恶心、呕吐严重程度均有所下降,但经独立t检验,两组患者恶心严重程度差异无统计学意义(P <0.05)。经卡方检验,两组受试者服药前恶心严重程度均为中度,服药后大部分受试者恶心严重程度减轻,归为轻度组。基于计划行为理论的教育可以显著影响分娩恐惧,提高阴道分娩率。由于jalinus糖浆和Ondansetron糖浆治疗妊娠期恶心呕吐的效果相似,且使用无副作用,因此可以使用草药代替化学药物。
{"title":"Comparison of the effect of jalinus syrup and ondansetron syrup on nausea and vomiting during pregnancy in pregnant women: randomized clinical trial","authors":"A. Shayan, S. Nazari, S. Nazari, H. Ahmadinia, M. Rahnavardi, F. Shobeiri, R. Bekhradi, A. Khalili","doi":"10.2174/1573404819666220629100218","DOIUrl":"https://doi.org/10.2174/1573404819666220629100218","url":null,"abstract":"\u0000\u0000This study aimed to compare the effect of jainus syrup and Ondansetron syrup on nausea and vomiting during pregnancy.\u0000\u0000\u0000\u0000The present study isa single-blindrandomized clinical trial that was conducted on 120 pregnant womenreferred to the health centers of Hamadan during 2017-2018 year.The participants were randomly divided into two groups of control and intervention with 60 subjects in each group.Two groups of 60 received jalinus syrup and Ondansetron syrup for 7 days. Data collection tools, demographic questionnaire, and information associated with pregnancy, and PUQE-24 questionnaire were used to assess the severity of nausea and vomiting, and questions related to the assessment of side effects as well asparticipants’ level of satisfaction with the treatment were provided. All the data were analyzed using the SPSS software version 16. P-value < 0.05 was considered significant.\u0000\u0000\u0000\u0000The severity of nausea and vomiting in both groups decreased after the intervention, but considering the independent t-test, there was no significant difference between the two groups in terms of severity of nausea (P <0.05). According to the Chi-square test, the severity of nausea of all participants was moderate in both groups before taking the medication, and after taking the medication, the severity of nausea reduced in most participants and they were placed in the mild group.\u0000\u0000\u0000\u0000Education based on the theory of planned behavior could significantly affect the fear of childbirth and increase the vaginal delivery rate\u0000\u0000\u0000\u0000Due to the similar effects of jalinus syrup and Ondansetron syrup in the treatment of nausea and vomiting in pregnancy and the absence of side effects arising from its use, herbal medicine can be used instead of chemical drugs.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":"43 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77568490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Women s Health Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1